跳至主要内容
临床试验/NCT01716143
NCT01716143Unknown不适用

Left Atrium Substrate Based Ablation Plus Circumferential Pulmonary Vein Isolation in the Treatment of Persistent and Long-standing Atrial Fibrillation

The First Affiliated Hospital with Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 87 人开始时间: 2010年3月最近更新:
适应症

试验速览

阶段
不适用
入组人数
87
试验地点
1
主要终点
The primary study end point was freedom from atrial arrhythmias off antiarrhythmic drugs at 3,6,12,18 and 24 months after a single-ablation. procedure.

研究概览

简要总结

The purpose of this study is to determine whether left atrium substrate based ablation plus circumferential is effective in the treatment of persistent and long-standing atrial fibrillation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All persistent or permanent AF patients with refractory or intolerant to at least one Class 1 or Class 3 antiarrhythmic medication.

排除标准

  • Patients with paroxysmal AF (self-terminating episodes lasting < 7 day)
  • Patients who have had a previous AF ablation procedure

结局指标

主要结局

The primary study end point was freedom from atrial arrhythmias off antiarrhythmic drugs at 3,6,12,18 and 24 months after a single-ablation. procedure.

时间窗: 3 years

次要结局

  • The percentage of macro-reentrant atrial tachycardia in recurrent arrhythmias after atrial fibrillation ablation(December 31, 2012)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Youquan Wei

Clinical Investigator

The First Affiliated Hospital with Nanjing Medical University

研究点 (1)

Loading locations...

相似试验

Left Atrium Substrate Based Ablation Plus... | 临床试验